NEXT Oncology- Dallas

Dallas, Texas 75230

3 studies enrolling now · 6 studies all time

What they study most

Advanced Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumors, Advanced or Metastatic KRAS-mutant Tumor, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer, Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, Bladder Cancer, Colorectal Cancer, Colorectal Carcinoma, Esophageal Adenocarcinoma

Studies at this site

• A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — Recruiting now
• Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors — Recruiting now
• Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. — Recruiting now
• A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors — Recruiting now
• Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors — Running, not enrolling
• Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors — Running, not enrolling